Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Phase III Study of 5-FU Continuous Infusion (5FUci) Versus MTX+5-FU Sequential Therapy (MF) in Gastric Cancer With Peritoneal Metastasis (JCOG0106-MF, MF/5FU)

NCT00149201 is registered in ClinicalTrials.gov with Japan Clinical Oncology Group as lead sponsor.

NCT NCT00149201
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00149201 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Phase III Study of 5-FU Continuous Infusion (5FUci) Versus MTX+5-FU Sequential Therapy (MF) in Gastric Cancer With Peritoneal Metastasis (JCOG0106-MF, MF/5FU)
Lead sponsor
Japan Clinical Oncology Group
Phase
Phase 3
Overall status
Completed
Start date
November 30, 2002
Completion date
April 30, 2008
Enrollment
160
Sites
34

Conditions

As the registry lists them; a condition with its own page is linked.

gastric cancer, neoplasm metastasis